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Abstract
In Escherichia coli, ppGpp is a major determinant of growth and glycogen accumulation. Levels of this signaling nucleotide
are controlled by the balanced activities of the ppGpp RelA synthetase and the dual-function hydrolase/synthetase SpoT.
Here we report the construction of spoT null (DspoT) mutants obtained by transducing a DspoT allele from DrelADspoT
double mutants into relA+ cells. Iodine staining of randomly selected transductants cultured on a rich complex medium
revealed differences in glycogen content among them. Sequence and biochemical analyses of 8 DspoT clones displaying
glycogen-deficient phenotypes revealed different inactivating mutations in relA and no detectable ppGpp when cells were
cultured on a rich complex medium. Remarkably, although the co-existence of DspoT with relA proficient alleles has
generally been considered synthetically lethal, we found that 11 DspoT clones displaying high glycogen phenotypes
possessed relA mutant alleles with non-inactivating mutations that encoded stable RelA proteins and ppGpp contents
reaching 45–85% of those of wild type cells. None of the DspoT clones, however, could grow on M9-glucose minimal
medium. Both Sanger sequencing of specific genes and high-throughput genome sequencing of the DspoT clones revealed
that suppressor mutations were restricted to the relA locus. The overall results (a) defined in around 4 nmoles ppGpp/g dry
weight the threshold cellular levels that suffice to trigger net glycogen accumulation, (b) showed that mutations in relA, but
not necessarily inactivating mutations, can be selected to compensate total SpoT function(s) loss, and (c) provided useful
tools for studies of the in vivo regulation of E. coli RelA ppGpp synthetase.
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Introduction
In conditions in which carbon sources are in excess and other
nutrients are deficient, Escherichia coli and many bacterial species
accumulate glycogen, a branched homopolysaccharide of a-1,4-
linked glucose subunits with a-1,6-linkages at the branching points
[1,2]. Synthesized by glycogen synthase (GlgA) using ADP-glucose
as the glucosyl moiety donor, the exact role of glycogen in
bacterial physiology is still not well defined, but several works have
linked this polysaccharide to a reserve source of energy and
carbon, environmental survival, intestine colonization, virulence,
etc. [1–3].
Glycogen metabolism in E. coli is regulated by a complex and
still not well defined assemblage of transcriptional and post-
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transcriptional factors that are adjusted to the nutritional status of
the cell [1,2]. We have recently re-evaluated the genetic basis of
glycogen gene expression and regulation [2,4–8] and found that,
contrary to the long prevailing view of the existence of two
separate and differentially regulated glgBX (encompassing the
genes coding for glycogen branching (GlgB) and debranching
(GlgX) enzymes), and glgCAP (encoding the GlgC and GlgA
anabolic enzymes as well as the catabolic glycogen phosphorylase
(GlgP)) glycogen operons [1], E. coli glycogen genes are organized
in a single glgBXCAP operon [7]. In a search for main
intracellular signals regulating glycogen metabolism in this model
organism, we found that glgBXCAP glycogen gene expression and
consequent glycogen accumulation were highly impaired in cells
bearing a relA null ((DrelA) allele [7]. These results reinforced long
proposals that the RelA product ppGpp controls glycogen
biosynthesis in E. coli [1,2]. Moreover, our studies indicated that
E. coli glycogen content was also reduced by mutations in other
regulatory genes with known links to ppGpp such as crp, rpoS,
glgS, rpoN, phoPQ, fis, dksA, hfq, etc. [4,5]. Since ppGpp lies at
the top of the network governing global gene expression in
response to nutrient availability [9–12], the overall observations
pointed to this nucleotide as a master controller of E. coli glycogen
metabolism.
Accumulation of ppGpp constitutes the hallmark of the so-
called stringent response, which is elicited in E. coli and many
other organisms facing amino acid starvation [9–12]. This
pleiotropic response was originally characterized by the rapid
(‘‘stringent’’) inhibition of stable (rRNA and tRNA) synthesis,
downregulation of the translational apparatus, and growth arrest
[9–12]. That ppGpp was the main controller of this response was
supported by the inverse correlation generally found between
ppGpp basal levels and bacterial growth rates [9–14]. Years of
experimentation indicate now that ppGpp actions extend to
fundamental aspects of bacterial biology including adaptability,
survival, stress responses, biofilm production, evolvability, patho-
genesis, etc. [9–12].
E. coli ppGpp cellular levels are regulated by the balanced
activities of RelA and SpoT, which share around 31% of amino
acid sequence identity and can both catalyze the phosphorylation
of GDP (or GTP) to ppGpp (or pppGpp) using ATP as the
phosphoryl donor [9–12]. RelA represents the main source of
ppGpp upon amino acid starvation, a condition in which lack of
aminoacyl-tRNAs activates ribosome-bound RelA to synthesize
this nucleotide [9–12]. SpoT, on the contrary, can produce ppGpp
under deprivation of sources other than amino acids such as
energy and carbon, phosphate, iron, and fatty acids [9–13]. Most
importantly, SpoT is also endowed with ppGpp hydrolase activity,
providing an essential function for the regulation of basal ppGpp
levels in the cell [9–14]. The dual activity of SpoT makes it
especially suitable for this purpose, since a small balance shift
between synthesis and hydrolysis would exert an immediate
impact on cellular ppGpp accumulation [9–12]. ppGpp binds
directly to the RNA polymerase, although it can act synergistically
or antagonistically with DksA (or other auxiliary factors) to exert
regulatory actions [9–12]. This binding alters RNA polymerase
performance resulting in decreased transcription at stringent
promoters [9–12]. Moreover, increased transcription at a few
RpoD- and alternative sigma factor (RpoN, RpoS, RpoF, and
RpoE)-dependent promoters also occur, resulting in the activation
of a number of biosynthetic operons as well as stress/survival
functions [9–12].
Besides the strident effects provoked by the rapidly elevated
levels of ppGpp resulting upon amino acid starvation, less
pronounced modifications in ppGpp basal levels (resulting from
subtle regulations of the balance between RelA and SpoT activities
provoked by limitation of certain nutrients) are thought to have
important physiological roles during cell growth [9–18]. Prevalent
ideas are that, as the nutritional quality of the medium deteriorates
and growth rate consequently diminishes, cells may be continu-
ously adjusting ppGpp basal levels to properly allocate resources
between biosynthetic and stress/survival functions [9–18]. In this
context, recent experimental evidence has shown the existence of
ppGpp-mediated hierarchical responses in global transcription
patterns to amino acid starvation in E. coli [16–18]. In one of
these works [17] two main regulatory circuits induced at different
ppGpp cellular concentrations provoked by isoleucine limitation
were identified. Thus, low basal ppGpp levels caused during
isoleucine shortage induced the Lrp regulon and amino acid
biosynthetic operons necessary for maintaining active growth,
while much higher ppGpp levels resulting from isoleucine
depletion induced growth arrest, and fully activated the RpoS-
mediated general stress response [17,18].
Different procedures are generally used to investigate the
regulatory involvement of ppGpp in a given process, all having
both advantages and drawbacks [9]. One common procedure
involves the starvation of a relA+ strain for a given amino acid.
This results in rapid and large increases in cellular ppGpp levels
with concomitant and measurable consequences, but has the
disadvantage of prematurely arresting cell growth and of inducing
a variety of undesirable stress responses [9,16,17]. Still, the
combination of this procedure with the use of isogenic bacteria
bearing highly defective or null relA alleles (i.e., ‘‘relaxed’’ strains),
either alone or in combination with deficient spoT alleles,
represents another commonly used strategy to uncover ppGpp
roles in a given process [9]. Single relA mutants can still produce
ppGpp due to SpoT activity, but the simultaneous deletion of relA
and spoT genes (DrelADspoT double mutants) generates bacteria
totally devoid of ppGpp (ppGpp0 cells) [9–12,19,20]. The latter
mutants exhibit auxotrophies for multiple amino acids, apparently
because ppGpp is required for the effective transcription of the
corresponding biosynthetic genes [9–12,19,20]. Another genetic
approach to manipulate ppGpp basal levels includes the use of
defective spoT alleles [9,14,15,20]. Still, severe spoT mutants were
generally assumed to survive only in highly deficient relA
backgrounds since conditional lethality was observed when the
corresponding spoT alleles were introduced into relA+ cells, an
effect attributed to the resulting high ppGpp cellular levels
promoted by unchecked RelA activity [9,14,20]. And last but
not least, different studies have indicated that the richer the culture
medium, the lower the cellular ppGpp levels [9,13,14]. It follows
that the use of enriched culture media could provide a useful
means for maintaining low ppGpp basal levels during cell growth.
Moreover, the use of enriched media could also help differenti-
ating changes elicited by small increases on basal ppGpp levels
(which are expected as the nutritional quality of the medium
slowly deteriorates) from changes derived from abrupt and large
ppGpp increases that generally accompany the rapid depletion of
a particular essential nutrient [9].
Considering the role of ppGpp as a main regulator of E. coli
glycogen metabolism and the function of this polysaccharide as a
reserve source of energy and carbon for long-term survival
discussed above, we found of interest to define with precision the
threshold ppGpp levels that promote net glycogen accumulation.
Towards this end we carried out sensitive HPLC/MS-based
analyses of ppGpp contents and measured glycogen gene
expression and glycogen accumulation in E. coli BW25113 cells
growing in a glucose-containing rich complex medium known as
Kornberg medium (KM) [21,22]. KM was originally utilized to
relA Suppressors of Total spoT Loss in E. coli
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grow E. coli cells for the isolation of DNA polymerase [21], and
has since provided a valuable tool for bacterial glycogen
metabolism research [1,2,4–8,22]. Moreover, in the course of
our studies we found that a DspoT::Spc null allele could be
transduced into BW25113 relA+ cells, and that the different spoT-
less clones selected under the employed conditions could be
separated in two main categories: i) DspoT clones with low
glycogen content due to reduced glycogen gene expression, no
detectable ppGpp, and relA alleles bearing different inactivating
mutations; ii) DspoT clones with high glycogen content due to
increased glycogen gene expression, significant ppGpp accumula-
tion, and different relA alleles bearing non-inactivating mutations.
Notably, none of these mutants could grow in M9-glucose,
indicating the essentiality of SpoT function(s) for this growth
mode. Also, high-throughput genome sequencing of 5 DspoT
clones supported the idea that suppressor mutations of SpoT
function(s) loss were centered at the relA locus. The overall results
(a) served to define the threshold levels required to trigger net
glycogen accumulation in E. coli to approximately 4 nmoles
ppGpp/g dry weight (DW) (b) showed that not necessarily
inactivating mutations in relA can be selected to compensate the
total loss of SpoT function(s), (c) pointed to the possible occurrence
of mechanism(s), other than SpoT-mediated ppGpp breakdown,
that prevent accumulation of toxic ppGpp levels, and (d) provide
an useful method for the systematic production of relA mutant
alleles encoding mutant variants with significant ppGpp synthe-
sizing capabilities. These mutants could serve useful purposes for
the study of many basic questions related to RelA structure/
function regulation and ppGpp biological roles. To our knowledge
this is the first work describing a procedure for the systematic
production of spoT null mutants of E. coli containing relA
suppressor alleles encoding active RelA proteins.
Materials and Methods
E. coli strains and culture conditions
Strains used in this work are shown in Table 1. The E. coli K-
12 BW25113 strain (lacIq rrnBT14 DlacZWJ16 hsdR514 DaraBA-
DAH33 DrhaBADLD78) and its isogenic DrelA mutants were
obtained from the Keio collection [23]. To analyze glycogen gene
expression, glycogen accumulation, and ppGpp levels, cells were
grown at 37uC with rapid gyratory shaking in liquid KM medium
(1.1% K2HPO4, 0.85% KH2PO4, 0.6% Difco yeast extract from
Difco, 50 mM glucose) supplemented with the appropriate
selection antibiotics after inoculation with 1 volume of an
overnight culture per 100 volumes of fresh culture medium.
Bacterial growth was followed spectrophotometrically by measur-
ing the Abs600 of the cultures at the different growth times
indicated in the Figures. Growth in minimal medium was tested as
described below using liquid M9 medium (95 mM Na2HPO4/
44 mM KH2PO4/17 mM NaCl/37 mM NH4Cl/0.1 mM
CaCl2/2 mM MgSO4) supplemented with 50 mM glucose. Solid
KM was prepared by addition of 1.5% bacteriological agar to
liquid KM before autoclaving.
Generation of DspoT::Spc cells
A selectable antibiotic resistance gene was generated by PCR
from a freshly isolated colony of E. coli MC4100 containing a Spc
resistance cassette, using 60 nucleotide-long primers SPOT1 and
SPOT2 (see Table S1) that included 40 nucleotides homology
extensions for the targeted locus (spoT) and 20 nucleotides priming
sequences for the resistance gene. This amplicon was introduced
into BW25113 DrelA::Km cells [23] to generate a DspoT::Spc
DrelA::Km double mutant following the method of Datsenko and
Wanner [24]. spoT disruption in these cells was confirmed by PCR
using the specific primer pairs (O1/O2 and O3/O4) described in
Table S2. A double mutant strain thus obtained was used to grow
P1 phage, and the lysates were used to transduce the DspoT::Spc
null allele to different E. coli genetic backgrounds (BW25113,
BL21, B/R and B) using conventional procedures. The cells were
plated on solid LB medium (10 g/L tryptone, 5 g/L yeast extract,
10 g/L sodium chloride and 1.5% bacteriological agar) containing
50 mg/ml Spc, and selected clones used for further analyses were
confirmed for the spoT disruption by PCR as above (Table S2
and Figure S2). For complementation analyses, the selected
DspoT clones were first transformed with the chloramphenicol
resistance-conferring plasmid pCA24N-spoT from the ASKA
collection, which directs expression of spoT under the control of
an IPTG inducible promoter [25]. The same DspoT clones were
also transformed with empty-vector constructs (pCA24N-EV) and
used as controls. In all cases the transformed chloramphenicol-
resistant cells were selected on LB supplemented with 25 mg/ml of
this antibiotic. To test complementation by spoT in M9-glucose
minimal medium, bacteria were first grown overnight in LB liquid
medium supplemented with the corresponding antibiotics. The
cells corresponding to a 1 ml aliquot of each saturated culture
were then collected by centrifugation, rinsed once and resus-
pended in 1 ml of M9 minimal medium, and used to inoculate
100 ml of M9-glucose minimal medium kept at 37uC. The
cultures were incubated under aerobic conditions at 37uC with
gentle agitation, and aliquots were taken at the indicated times to
measure Abs600 in order to follow growth kinetics.
ppGpp extraction and HPLC/MS analysis
A novel and highly sensitive HPLC/MS ppGpp determination
procedure was employed for this work. In short, ppGpp was
extracted from bacterial cells grown in KM employing a two-step
(quenching and extraction) procedure. In step one, bacterial cells
corresponding to 20 mL of cell cultures were collected by
centrifugation at the indicated culture times, treated with 20 mL
of pre-cooled quenching solution (80% methanol containing
0.85% (w/vol) ammonium bicarbonate) at –50uC [26,27], and
centrifuged at –17uC for 5 min at 30006g. The pellet thus
obtained was rapidly frozen with liquid nitrogen and stored at
–86uC. In step two, the pellets were resuspended in 2 mL of a
nitrogen-saturated solution of acetonitrile/10 mM KH2 PO4 (pH
7.4) (3:1; v:v) using a rotator stirrer set at 12 rpm during a 30 min
period at 4uC. After centrifugation at 155006g for 20 min at 4uC,
the supernatants were extracted by vigorous agitation with 4 mL
chloroform and centrifuged at 155006g for 5 min at 4uC. This
procedure was repeated three times with the upper aqueous phase,
which was finally collected and filtered for subsequent analysis.
ppGpp was measured with an Agilent 1200 HPLC instrument
(Agilent Technologies, California, USA) controlled by the
Chemstation software, and coupled to an Agilent 6120 single
quadrupole mass spectrometer with an orthogonal ESI source
working in the positive mode for single ion monitoring (m/
z = 604). The separation was carried out at 25uC [28] on 10 ml
samples, using a ZIC-HILIC column (15064.6 mm, 5 mm particle
size). Elution was conducted at a flow rate of 0.5 mL/min with
mixtures of 20 mM ammonium acetate (pH 7.5) in either H2O
(solvent A) or acetonitrile (solvent B). Gradient elution was
performed by increasing solvent A from 0 to 80% during a
30 min period, and then starting conditions were re-established in
1 min followed by re-equilibration for further 14 min. The
detector operating parameters were: ion spray voltage: 4000 V;
nitrogen flow: 12 L/min; fragmentation voltage: 100 V.
EasyLCMS [29] was used for automated quantification. The
relA Suppressors of Total spoT Loss in E. coli
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Table 1. E. coli strains used in this study.
Designation Description Source Comments
WT BW25113 (lacIq rrnBT14
DlacZWJ16 hsdR514 DaraBADAH33
DrhaBADLD78)
Keio collection [23] -
DrelA BW25113 DrelA::KmR Keio collection [23] rpoS, dksA, rsd, ssrS, rpoC, rpoZ and rpoB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing)
DrelA* BW25113 DrelA::KmR
derivative in which the Km-
resistance cassette was removed
(KmS)
Montero et al. [7] rpoS, dksA, rsd, ssrS, rpoC, rpoZ and rpoB sequences are identical to the
corresponding genes in BW25113
(as determined by Sanger sequencing)
DrelADspoT BW25113 DrelA*
DspoT:: SpcR
This work rpoS, dksA, rsd, ssrS, rpoC, rpoZ, rpoB, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing)
DspoT-1 BW25113 DspoT:: SpcR,
clone 1
This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). relA
contains a deletion of 4 nt between positions +138 to +142 resulting in a frameshift
that introduced a TAA stop codon at nt positions 202–204. Encodes a truncated
polypeptide of 67 amino acids, the first 46 from the RelA N-terminal region
DspoT-2 BW25113 DspoT:: SpcR, clone 2 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding
genes in BW25113 (as determined by Sanger sequencing). relA contains a deletion
of 2 nt at positions +360 and +361 resulting in a frameshift that introduced a TGA
stop codon at nt positions 370–372. Encodes a truncated polypeptide of 123 amino
acids, the first 119 from the RelA N-terminal region
DspoT-3 BW25113 DspoT:: SpcR, clone 3 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). relA
contains an insertion of 1 nt at position +544 resulting in a frameshift that
introduced a TAA stop codon at nt positions 559–561. Encodes a truncated
polypeptide of 186 amino acids, the first 181 from the RelA N-terminal region
DspoT-4 BW25113 DspoT:: SpcR, clone 4 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). relA
contains a G for T mutation at nt position +568 that introduced a premature TGA
stop codon. Encodes a RelA N-terminal truncated polypeptide of 189 amino acids.
DspoT-5 BW25113 DspoT:: SpcR, clone 5 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, rplK, rpoD, yejB and glnB sequences are
identical to the corresponding genes in BW25113 (as determined by Sanger and
high throughput sequencing). relA contains a G for T mutation at nt position +658
that introduced a premature TAA stop codon. Encodes a RelA N-terminal truncated
polypeptide of 219 amino acids
DspoT-6 BW25113 DspoT:: SpcR, clone 6 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). relA
contains a deletion of 7 nt at positions +1005 to +1011 resulting in a frameshift that
introduced a TGA stop codon at positions 1132–1134. Encodes a truncated
polypeptide of 377 amino acids, the first 335 from the RelA N-terminal region
DspoT-7 BW25113 DspoT:: SpcR, clone 7 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). relA
disrupted by an insertion sequence (IS1, 777 bp) located at nt +24
DspoT-8 BW25113 DspoT:: SpcR, clone 8 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). relA allele,
contains a C for A mutation at nt +774 resulting in S258R replacement, polypeptide
detected by western blot
DspoT-9 BW25113 DspoT:: SpcR, clone 9 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). relA allele,
contains a G for A mutation at nt +658 resulting in E220K replacement, polypeptide
detected by western blot
DspoT-10 BW25113 DspoT:: SpcR, clone 10 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, rplK, rpoD and glnB sequences are identical to
the corresponding genes in BW25113 (as determined by Sanger and high
throughput sequencing). relA allele, contains a G for A mutation at nt +1042
resulting in E348K replacement, polypeptide detected by western blot. yejB allele
contains a G for T mutation at nt position 142 resulting in the introduction of a
premature TGA stop codon, codes for a putative truncated polypeptide of 47 amino
acids
DspoT-11 BW25113 DspoT:: SpcR, clone 11 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, rplK, rpoD, yejB and glnB sequences are
identical to the corresponding genes in BW25113 (as determined by Sanger and
high throughput sequencing). relA allele, contains a A for C mutation at nt +346
resulting in I116L replacement, polypeptide detected by western blot
relA Suppressors of Total spoT Loss in E. coli
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quality of the results was assessed by (i) evaluation of the extraction
method with standard mixtures; (ii) the use of an internal standard
and (iii) quality control samples. The extraction method was
validated by comparing the concentration of ppGpp standard
mixtures before and after extraction, with ppGpp recoveries
higher than 85% in all cases. The ppGpp standard was purchased
from TriLink Biosciences. Thymine-methyl-d3-6-d (m/z 131) was
added as internal standard (final concentration of 50 mM) to the
samples to monitor the robustness of the analysis [30]. The
acceptable coefficient of variation was set at 20% for the peak area
and 2% for the retention time. Two types of quality controls were
incorporated to the analysis including pools of samples and
standards.
Other analytical procedures
For the quantitative analyses of glycogen contents, the cells were
grown in KM as described above, harvested at the indicated
culture times, collected by centrifugation at 44006g for 15 min,
rinsed with fresh KM, resuspended in 40 mM Tris/HCl (pH 7.5),
and disrupted by sonication as previously described [5,7].
Quantitative glycogen measurement analyses were carried out in
these extracts by using an amyloglucosidase based test kit
(Boheringer Manheim). Protein content was measured by the
Bradford method using a Bio-Rad prepared reagent, and b-
galactosidase activity as described by Miller [31]. Qualitative
analysis of glycogen content of cells cultured on solid KM was
carried out using the iodine staining technique [22].
Western blot analyses
The different BW25113 strains and derived DspoT clones
analyzed in this work were cultured in liquid KM as described
above and harvested after 7 h of culture. The cells were collected,
rinsed, and subjected to sonic disruption as described previously
[5,7]. The bacterial extracts thus obtained were clarified by
centrifugation (150006g for 10 min), and total protein content was
determined in the supernatants as described above. Soluble
Table 1. Cont.
Designation Description Source Comments
DspoT-12 BW25113 DspoT:: SpcR, clone 12 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, rplK, rpoD, yejB and glnB sequences are
identical to the corresponding genes in BW25113 (as determined by Sanger and
high throughput sequencing). relA allele, contains a C for T mutation at nt +655
resulting in H219Y replacement, polypeptide detected by western blot
DspoT-13 BW25113 DspoT:: SpcR, clone 13 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, rplK, rpoD and yejB sequences are identical to
the corresponding genes in BW25113 (as determined by Sanger and high
throughput sequencing). relA allele, contains a G for A mutation at nt +589 resulting
in E197K replacement, polypeptide detected by western blot. glnB allele contains a
3 bp deletion eliminating nucleotides 82 to 84 resulting in GlnB lacking M28
DspoT-14 BW25113 DspoT:: SpcR, clone 14 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by anger sequencing). relA allele,
contains a G for C mutation at nt +287 resulting in R96P replacement, polypeptide
detected by western blot
DspoT-15 BW25113 DspoT:: SpcR, clone 15 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). relA allele,
contains a A for T mutation at nt +392 resulting in Q131L replacement, polypeptide
detected by western blot
DspoT-16 BW25113 DspoT:: SpcR, clone 16 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). relA allele,
contains a T for A mutation at nt +682 resulting in Y228N replacement, polypeptide
detected by western blot
DspoT-17 BW25113 DspoT:: SpcR, clone 17 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). relA allele,
contains a C for T mutation at nt +757 resulting in P253S replacement, polypeptide
detected by western blot
DspoT-18 BW25113 DspoT:: SpcR, clone 18 This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). relA allele,
contains a G for T mutation at nt +953 resulting in G318V replacement, polypeptide
detected by western blot
DspoT-19 BW25113 DspoT:: SpcR,
clone 19
This work - rpoS, dksA, rsd, ssrS, rpoB, rpoC, rpoZ, yejB and glnB sequences are identical to the
corresponding genes in BW25113 (as determined by Sanger sequencing). RelA allele
contains a 3 bp deletion eliminating nucleotides +115 to +117 resulting in a RelA
variant lacking W39, polypeptide detected by western blot
DrelA glgB::lacZY BW25113 glgB::lacZY
transcriptional fusion in
DrelA*
Montero et al. [7] -




DspoT-N glgB::lacZY glgB::lacZY transcriptional
fusion in DspoT-N (N: 1 to 19)
This work -
SpcR, spectinomycin resistance. KmR, kanamycin resistance. DspoT clones that were subjected to high-throughput genome sequencing are indicated in bold.
doi:10.1371/journal.pone.0106938.t001
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fractions corresponding to 70 mg of total proteins were subjected to
SDS/PAGE (10% polyacrylamide gels), transferred to polyviny-
lidene difluoride filters (Bio-RAD, Hercules, CA, USA), and
immunodetected by using anti-RelA mouse monoclonal antibodies
(Santa Cruz Biotechnology, CA, USA) and goat anti-mouse IgG
alkaline phosphatase conjugates. Immunoblots were developed
with the 4-chloro-3-indolyl phosphate/nitroblue tetrazolium
method. Alternatively, a goat anti-mouse IgG peroxidase conju-
gate (Sigma) was used as a secondary antibody and immunoblots
were developed with Supersignal West Femto (Thermo scientific,
IL, USA) followed by exposure to autoradiograph films.
High-throughput whole genome sequencing
DNA fragment library preparations and pyrosequencing
strategies. Bacterial DNA was extracted and purified by using
the High Pure PCR Template Preparation Kit (Roche, Mann-
heim, Germany). Purified DNA was quantified by using a Quant-
iT PicoGreen DNA quantification kit (Life Technologies) in a Bio-
RAD VersaFluor Fluorometer. Depending on the sequencing
strategy followed, the DNA samples were differentially treated as
follows: For 454 pyrosequencing (Genome Sequencer FLX,
LifeSciences, Roche Diagnostics, Branford, CT, USA) the samples
were fragmented with the aid of a nitrogen nebulizer (400–800 nt
length), followed by ligation to the sequencing adapters, emPCR,
and sequencing following the manufacturer’s specifications. For
Illumina sequencing (HiSeq 2000 system, Illumina Inc., San
Diego, CA, USA), the DNA samples were fragmented with the aid
of a Covaris S220 Focused-ultrasonicator (Covaris, Woburn, MA,
USA) (250–700 nt length) followed by ligation to the adaptors and
sequencing following the manufacturer’s specifications. The
BW25113 genome was sequenced using both the 454 and
Illumina platforms, whereas the rest of the strains were sequenced
with the Illumina platform only.
Quality control, assembly and mapping of sequence
reads. Only Illumina and 454 sequence reads with Q-values
$30 and $25, respectively, were included in the analysis. All
reads derived from the BW25113 (WT) strain were assembled
using an incremental assembly procedure (Newbler version 2.6;
454 LifeSciences, Roche Diagnostics) with default parameters,
except that the minimum length overlap and read length were set
at 30 nt. 454 long reads were first assembled in a backbone where
shorter Illumina reads were introduced and assembled. Assembly
of the contigs corresponding to the WT strain was done using
MAUVE [32] using as scaffold the genome of E. coli MG1655
(GenBank accession number NC_000913). The genome data
obtained from the analyzed DspoT clones (5 and 10 to 13) were
mapped using the gsMapper program version 2.6 (454 Life-
Sciences, Roche Diagnostics) with default parameters using the
WT assembly data as reference to detect High Confidence
Variations (HCDiffs) in the mutants.
Genome annotation and mutational profiling. All assem-
bled contigs from the WT strain were introduced into the
annotation pipeline implemented at Lifesequencing (Valencia,
Spain). After searching the data for coding sequences, open
reading frames and structural RNA (tRNA and rRNA) genes, the
derived coding sequences and open reading frames (canonical and
non-canonical) were associated to specific function(s) using
BLASTX [33]. We also assigned GO terms and searched for
any over-represented function taking into account annotated genes
(http://www.geneontology.org/). Genes associated to a PFAM or
Enzymatic code were also subjected to KEGG pathway mapping
(http://www.kegg.jp/) [34]. Once the genome of the WT strain
was annotated, HCDiffs mutations were mapped in each of the
evolved strains and associated to specific genes. The number of
HCDiffs mutations occurring in each gene was then calculated,
and a mutational profiling was performed to allow the identifica-
tion of genes in specific DspoT clones that accumulated more
mutations than others. The genome sequence data of E. coli
BW25113 WT and DspoT clones obtained in this work were
deposited in the European Nucleotide Archive (EMBL-EBI) with
the accession number PRJEB6520.
Gene amplification and sequencing
relA, dksA, rsd, ssrS, glnB, yejB, rpoB, rpoS, rpoC and rpoZ
genes and their immediate surrounding sequences, and sequences
of the genomes of WT cells and DspoT clones that differed in the
high-throughput sequencing analyses were amplified by PCR
using the oligonucleotides described in Table S2 (see also Figure
S2). The amplicons thus obtained were subjected to Sanger
sequencing at the Secugen S.L. DNA sequencing service (Madrid,
Spain).
Results and Discussion
Correlation between glycogen accumulation and ppGpp
levels in E. coli cells growing in KM
We selected KM for the experiments described in this work,
reasoning that the use of enriched culture media for E. coli growth
should allow a better definition of the threshold ppGpp cellular
levels required to trigger glycogen accumulation. KM is composed
of surplus glucose, yeast extract as a source of nitrogen compounds
and vitamins, and a relatively high potassium phosphate concen-
tration [21]. The glucose provides a surplus source of energy and
carbon allowing steady growth to higher densities [35] and also net
glycogen accumulation [22]. The yeast extract (0.6%) is the main
source of most amino acids in both free and short peptides form
[36,37]. Finally, the relatively high potassium phosphate concen-
tration (ca. 126 mM) is not only a surplus phosphate source but
also helps maintaining the medium pH within limits compatible
with cell growth [35].
We first measured the intracellular ppGpp contents and carried
out time course analyses of growth, glycogen content, and
glycogen gene expression (as judged by the use of isogenic cells
bearing the corresponding glgB::lacZY fusions) of WT, DrelA and
DrelADspoT (ppGpp0) cells in KM. As shown in Figure 1A,
ppGpp contents in the WT strain at the exponential phase of
growth were below detection limits (which were set at 0.6 nmol
ppGpp/g DW for the HPLC/MS procedure used here). From this
time period to the stationary phase the ppGpp levels in WT cells
increased to around 22 nmoles ppGpp/g DW (Figure 1A).
Expectedly, DrelADspoT double mutants showed no detectable
ppGpp, a situation similar to DrelA single mutants which also
showed ppGpp levels below detection limits (Figure 1A). These
results indicate that (a) RelA is the major source of ppGpp in E.
coli cells growing in KM, and (b) the ppGpp synthetic activity of
SpoT is largely impaired under these growth conditions, as judged
by the absence of measurable ppGpp levels in DrelA mutants.
Since the RelA system serves the cell to monitor amino acid
availability and ppGpp is rapidly degraded [9], the basal ppGpp
levels found in WT cells in the stationary phase indicated
substantial RelA activation and therefore that amino acid sources
in KM were limiting during this phase. Experimental evidence
indicated in fact that particular amino acids are sequentially
depleted during E. coli growth in rich complex media [35,38].
As seen in Figure 1B, growth of both the WT and DrelA
strains in KM occurred at similar rates during the first 2 h of
growth (doubling times of 2761 min and 2861 min, respectively),
reaching Abs600 values of 0.8–1.0. After this period growth began
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to slow down in these two strains with a more pronounced effect
observed in the DrelA mutant, although the final Abs600 at the
stationary phase reached in both cases values of 4–5 (Figure 1B).
As seen in the figure, growth of the DrelADspoT double mutant
was slower than that of WT and DrelA cells (doubling time of
3763 min), although it finally reached Abs600 values of 4–5 after
7–10 h of growth (Figure 1B). It is worth noting that reductions
in growth rates of DrelADspoT double mutants in other complex
rich medium such as LB have been reported previously using
different E. coli K-12 strains [15,38]. In one of these studies [38]
genetic evidence was additionally provided for the requirement of
basal levels of ppGpp to induce an alternative pathway of synthesis
of glutamine, an amino acid in short supply in either yeast extract-
or peptone digest-based media [36,38] and a required nitrogen
donor for the synthesis of amino sugars, NAD, p-aminobenzoate,
purines, pyrimidines, histidine, and tryptophan [39]. This could
explain the differences in growth behavior between the WT strain
and DrelADspoT double mutant in KM observed above.
Moreover, the DrelA single mutant seemingly adapted easier to
this emerging metabolic necessity (Figure 1B), thus suggesting the
synthesis of at least trace amounts of ppGpp as the result of SpoT
action in these cells.
Concerning glycogen synthesis, it was observed for the WT
strain that both glycogen gene expression (Figure 1C) and
concomitant glycogen accumulation (Figure 1D) departed from
basal levels after the culture surpassed the middle of the
exponential phase, increased steadily during the onset of the
stationary phase, and ceased abruptly as growth stopped. On the
contrary, glycogen gene expression and glycogen accumulation in
both DrelADspoT and DrelA cells showed much lower increases
above basal levels (Figure 1C, D). We infer from our data that
whereas DrelADspoT cells accumulate no ppGpp, DrelA cells
could synthesize trace (but still below the detection limits of the
HPLC/MS assay used here) levels of ppGpp as the result of SpoT
action that were sufficient to stimulate growth but not glycogen
gene expression in DrelA cells.
The above results reinforced our previous observations that
ppGpp represents a main positive regulator of glycogen gene
expression and glycogen accumulation in E. coli [2,5,7]. More-
over, they also expanded our knowledge on the threshold ppGpp
levels required to trigger net accumulation of this polysaccharide,
which can be set at less than 22 nmoles ppGpp/g DW. It is worth
noting that these values are in the range of the basal ppGpp levels
determined by other authors for E. coli strains also growing in rich
media supplemented with glucose, which ranged from ,10 to
40 nmoles ppGpp/g DW [13,40,41]. Furthermore, these ppGpp
levels are certainly much lower that those associated with the
induction of RpoS-mediated stress responses in E. coli [17]. Our
results also show that increases on glycogen gene expression and/
or glycogen contents may provide reliable indicators of modifica-
tions of low basal levels of ppGpp associated to perturbations in
steady state physiological growth.
Production of DspoT cells
We next attempted the manipulation of the basal levels of
ppGpp in E. coli by constructing mutants deficient in ppGpp
degradation. All efforts to introduce a DspoT::Spc or a DspoT::Km
allele into BW25113 relA+ cells by the Datsenko and Wanner
procedure [24] repeatedly failed in our hands. On the contrary,
the transduction of the DspoT::Spc allele using P1 lysates of
DrelADspoT cells into BW25113 (relA+) cells allowed us the
selection of DspoT::Spc mutants as confirmed by both growth in
Spectinomycin (Spc)-containing LB solid medium and the inability
to amplify the WT spoT gene by PCR in these cells (see below).
We also succeeded in transducing by the same P1-transduction
procedure the DspoT::Spc null allele into other E. coli back-
grounds including the B strains BL21 and B (not shown).
The characterization by colony iodine staining [22] of 102
randomly-selected Spc-resistant transductants cultured in solid
Figure 1. Growth, ppGpp and glycogen contents in BW25113
WT, DrelA and DrelADspoT cells cultured in KM medium. (A)
ppGpp content at the exponential and stationary phases, and time-
courses of (B) growth, (C) chromosomal glgB::lacZY fusion expression,
and (D) glycogen contents in WT cells, DrelA cells and DrelADspoT cells.
In ‘‘A’’, cells at the exponential growth phase were harvested after
100 min of culture, whereas cells at the stationary phase were collected
after 7 h of culture.
doi:10.1371/journal.pone.0106938.g001
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KM revealed substantial differences in glycogen content among
them (Figure 2). As judged by visual inspection, approximately
18% of the colonies showed WT glycogen, 32% low glycogen and,
unexpectedly, around 50% displayed high glycogen content
phenotypes. Since ppGpp basal contents regulate glycogen gene
expression and subsequent glycogen accumulation (see above),
these results suggested wide differences in ppGpp basal contents
among these DspoT clones. We thus selected 19 of them for further
biochemical and genetic analysis: 8 with low glycogen (DspoT
clones 1–8) and 11 with high glycogen (DspoT clones 9–19) content
phenotypes (see Table 1). The selected 19 DspoT clones were
cultured in Spc-containing medium and the presence of the
DspoT::Spc deletion in each of these clones was confirmed by the
inability to amplify the WT spoT gene by PCR (Figure S1).
Characterization of DspoT clones in KM
We next analyzed ppGpp and glycogen content, and glycogen
gene expression at the stationary phase in the selected 19 DspoT
clones grown in liquid KM. DspoT clones #1–8 showed ppGpp
levels below detection limits at the stationary phase (Figure 3A).
Expectedly, and similar to DrelA or DrelADspoT mutants (cf.
Figure 1), DspoT clones #1–8 exhibited both reduced glycogen
gene expression and reduced glycogen content (Figure 4). In
clear contrast, DspoT clones #9–19 exhibited 45–85% of the
ppGpp contents found for the WT strain in the stationary
phase (Figure 3A) and showed higher glycogen contents as
the consequence of elevated glycogen gene expression levels
(Figure 4).
We also conducted time-course analyses of growth, expression
of glycogen genes, and glycogen content of the 19 selected DspoT
clones cultured in KM. Two representative examples of DspoT
clones with low glycogen content (clones#3 and#7) and two with
high glycogen content (clones #9 and #11) are shown to illustrate
the results (Figure 5). These analyses indicated that growth
behavior of DspoT clones #1–8 was comparable to that of DrelA
single mutant (cf. Figure 1B). That is, growth proceeded
exponentially for a period of about 2 h with calculated doubling
times of 3062 min to Abs600 values of around 0.6–0.8, and then
slowed down, finally reaching Abs600 values of 4–5 after 6–7 h
(Figure 5A). Similar to the situation found at the stationary phase
(cf. Figure 3A), ppGpp contents were below detectable limits at
the exponential phase in DspoT clones #1–8 (Figure 3B), thus
explaining their largely reduced or null induction of glycogen gene
expression and glycogen accumulation during growth (Figur-
es 5B and 5C). For DspoT clones #9–19 growth behavior was
comparable to that of DspoT clones #1–8, being exponential in all
cases for about 2 h with doubling times of 2962 min to Abs600
values of around 0.7–0.9, and then slowed down reaching Abs600
values of 4–5 after 6–7 h (Figure 5A). These clones, however,
showed time-course profiles of glycogen gene expression and
concomitant glycogen content similar to those of the WT strain
except that at higher values at any equivalent time (Figures 5B
and 5C). These results suggest the presence of basal levels of
ppGpp significantly higher than those of WT cells during
exponential growth. In line with this presumption, an average of
ca. 4 nmoles ppGpp/g DW was detected in DspoT clones #9–19
after 100 min of growth in KM (Figure 3B). The premature rise
of basal ppGpp levels in these clones did not affect growth to a
significant extent as judged by the similar growth curve profiles
obtained for DspoT clones#9–19 and #1–8 (Figure 5A and data
not shown).
The results obtained so far indicated that the introduction of a
DspoT null allele into relA+ cells of E. coli resulted not only in the
(expected) selection of relA mutants lacking ppGpp synthesis
capability, but also in a significant percentage of clones (DspoT
clones #9–19) bearing relA alleles containing non-inactivating
mutations as judged by the measurable levels of ppGpp at the
exponential phase of growth in KM (in average, 4 nmoles ppGpp/
g DW, cf. Figure 3B). This, in turn, resulted in concomitant
induction of glycogen gene expression and glycogen accumulation
well above basal levels. Moreover, additional increases of basal
ppGpp levels were observed in these particular clones as cells
entered into the stationary phase, as judged both by ppGpp
determinations after 7 h of growth (average of 14 nmoles ppGpp/
g DW, cf. Figure 3A) and further inductions of glycogen gene
expression and glycogen accumulation (Figures 5B and 5C).
These results are compatible with the presence in DspoT clones
#9–19 of mutant RelA proteins variants retaining both enzymatic
capability and inducible properties as growth proceeded and
nutrient sources became exhausted. They also pose the question
on whether all the relA suppressor alleles selected in these DspoT
clones code for RelA variants displaying increased basal levels of
ppGpp-synthesizing activity, or the WT RelA itself displays low
basal ppGpp synthesizing activity in cells that are not nutritionally
limited which could be exposed only by the complete removal of
spoT as reported here. The latter alternative could also explain the
question as to why ppGpp accumulates at all in cells that are not
limited for amino acids or aminoacyl-tRNA when RelA is
overproduced from plasmids [9].
Another important conclusion derived from the analysis of
DspoT clones #9–19 concerns the threshold ppGpp levels that
suffice to induce glycogen gene expression and concomitant
glycogen accumulation in E. coli, which can be set now in around
4 nmoles ppGpp/g DW as judged from the above results.
Figure 2. Glycogen iodine staining of DspoT clones. Iodine
staining of BW25113 (WT), DrelADspoT double mutants, and 102
independent DspoT clones cultured in solid KM. In the presence of
iodine vapors, ‘‘glycogen-excess’’ mutants stain darker than WT cells,
whereas ‘‘glycogen-deficient’’ and ‘‘glycogen-less’’ mutants stain yellow.
doi:10.1371/journal.pone.0106938.g002
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Characterization of DspoT clones in M9-glucose minimal
medium
Likely due to the multiple amino acid auxotrophies resulting
from their ppGpp0 status, E. coli DrelADspoT double mutants are
generally unable to grow in minimal media containing glucose and
ammonia as carbon and nitrogen sources, respectively [9,20]. On
the contrary single DrelA mutants are capable of growing in such
media, a situation attributed to the SpoT-mediated synthesis of
ppGpp to levels promoting expression of amino acid and other
biosynthetic operons [9,20,42]. In agreement, BW25113DrelAD-
spoT double mutants were unable to grow in M9-glucose minimal
medium, a phenotype which could be reverted by the expression
of spoT from plasmids (Figure 6). Also, BW25113DrelA single
mutants displayed a growth behavior similar to that of WT cells
thus reinforcing the role of SpoT as a source of ppGpp required
for growth in M9-glucose.
Considering the different ppGpp synthesizing capabilities of the
two different groups of DspoT clones described above, we thus
found of interest to compare their growth behavior in M9-glucose
(Figure 6). Similar to DrelADspoT double mutants, DspoT clones
#1–8 lacking detectable ppGpp production showed severe grow
impairments in minimal medium (Figure 6 and data not shown).
This represented an expected behavior considering the lack of
detection of ppGpp in these cells (Figure 3), suggesting either null
or very low production of this nucleotide to levels still incapable to
activate biosynthetic operons necessary for growth in minimal
medium. In agreement, the growth impairments shown by DspoT
clones #1–8 was reverted by the introduction of a spoT-expressing
plasmid in the cells (Figure 6). This reinforced the above notion
of essential functions of SpoT for the growth of these cells in
minimal medium. Remarkably, DspoT clones #9–19 (which
showed the capability to accumulate significant amounts of ppGpp
in KM, see above) were also severely impaired to grow in M9-
glucose (Figure 6). Moreover, the growth blockage phenotype of
these DspoT clones could also be reverted by the expression of
spoT in trans from plasmids (Figure 6).
The above observations can be explained in many ways. The
combined evidence of the growth behavior phenotypes of WT,
DrelA, DrelADspoT, and DspoT clones #1–8 in M9-glucose,
including the fact that spoT complementation in trans restored
growth of both DrelADspoT double mutants and DspoT clones in
this medium, supports the notion that SpoT can provide the
ppGpp basal levels required for E. coli to initiate growth under
these conditions. The lack of growth of DspoT clones #9–19 (all
retaining substantial ppGpp synthesis capability, see above) could
be explained by assuming that a rapid burst of RelA-mediated
Figure 3. ppGpp contents in WT cells and in the 19 selected DspoT clones. Cells were cultured in liquid KM and harvested (A) at the
stationary phase (after 7 h of culture) or (B) at the exponential growth phase (after 100 min of culture). The results are the mean 6 SE of 3
independent experiments. Growth curves of WT and four representative DspoT clones are shown in Figure 5A.
doi:10.1371/journal.pone.0106938.g003
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ppGpp accumulation reaching levels impairing growth occurred
when these cells were transferred to M9-glucose. In such a case,
the provision of spoT in trans would reinstate the ppGpp
hydrolytic activity necessary to prevent excessive ppGpp accumu-
lation, thus allowing growth to proceed [20,42]. Another
possibility, which is not mutually exclusive with the others is that,
concomitant to its participation in ppGpp metabolism, SpoT plays
other function(s) necessary for E. coli growth in M9-glucose. In this
context SpoT has been shown to physically interact with essential
proteins such as the acyl carrier protein involved in fatty acid
biosynthesis, an interaction related to the activation of the SpoT
ppGpp synthase activity in conditions of fatty acid starvation [42].
SpoT has also been shown to interact with ObgE/CgtA, a weak
GTPase involved in cell division, ribosome functions, and
regulation of the pppGpp/ppGpp cellular ratio during amino
acid starvation [43,44]. The biological significance of this
interaction remains poorly defined, but the possibility of other
essential roles of SpoT for E. coli growth under minimal
conditions deserves further studies.
High levels of genetic polymorphism at the relA locus
among the selected DspoT clones
Reasoning that survival of DspoT mutants could be ascribed to
mutations in relA, we sequenced the relA in all of the 19 selected
DspoT clones. As shown in Table 1 and Figure 7, these analyses
revealed different inactivating mutations at the relA locus in DspoT
clones 1 to 8 including: i) Nonsense mutations in DspoT clones
#1–6 introducing premature stop codons at different positions
within the coding region of the 455 amino acid residues N-
terminal domain possessing the ppGpp synthetase catalytic site
[9,45]. In the resulting truncated polypeptides this catalytic region
is either completely removed or severely reduced in length
depending on the clone analyzed (Figure 7A); ii) an IS1 insertion
sequence immediately downstream of the relA initiation codon in
DspoT clone #7, and; iii) a missense mutation in DspoT clone #8
resulting in the replacement of a Ser residue located at position
258 for an Arg (S258R) (Table 1, see also Figure 7). In
agreement with the relA sequencing results and the absence of
ppGpp, immunoblot analyses indicated no detectable RelA
proteins in DspoT clones #1–7 (Figure 8). In the case of DspoT
clone #8, the S258R replacement highly impaired ppGpp
Figure 4. Glycogen contents and expression of chromosomal glgB::lacZY fusions in the 19 selected DspoT clones. Glycogen content and
expression of chromosomal glgB::lacZY fusion at the stationary phase (after 7 h of culture) in WT cells, and in the 19 selected DspoT clones cultured in
KM. Data are referred to as percentage of glycogen measured in WT cells. In ‘‘A’’, average glycogen content in WT cells was equivalent to 257 nmol
glucose/mg protein. In ‘‘B’’, average level of glgB::lacZY expressions in WT cells was 312 Miller units [31]. The results are the mean 6 SE of 3
independent experiments.
doi:10.1371/journal.pone.0106938.g004
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synthesis capability as judged by the lack of detection of ppGpp in
this mutant (Figure 3). Still, this mutation allowed the synthesis of
a full-length, metabolically stable RelA protein, as judged by its
presence in the soluble fractions of cell extracts (Figure 8). It is
worth noting that replacement of the equivalent Ser residue
located in the catalytic loop of the RelA/SpoT (Rsh) bifunctional
enzyme of Streptococcus equisimilis (Ser247, Figure 7B) also
impaired ppGpp synthesis [46]. The combined observations
described above provide a reasonable explanation for the lack of
detection of ppGpp in DspoT clones #1–8.
For DspoT clones #9 to #19 sequence analysis indicated the
presence of missense mutations in relA located at different
positions all along the N-terminal coding region of RelA (clones
#9–18) and a deletion of a nucleotide triplet (clone #19)
corresponding to Trp39 (Table 1 and Figure 7). In all of these
clones the presence of RelA in the corresponding soluble cell
fractions was detected by immunoblot analysis (Figure 8). This,
in addition to the substantial ppGpp accumulation (Figure 3),
indicated that metabolically stable and catalytically competent
RelA variants were produced in all of these DspoT clones.
Expectedly, many of the amino acid changes were located either in
the close immediate region (E197K) or within (H219Y, Y228N,
P253S, G318V, and E351K) the ppGpp synthetase homolog
domain of RelA (Figure 7B). This supports the idea that these
particular RelA mutations could account for the reductions in
ppGpp accumulation described above for these DspoT clones.
Most remarkably, other changes also associated to reductions in
ppGpp accumulation such as the Trp39 deletion and the R96P,
I116L, and Q131L replacements are located in the N-terminal
region of RelA displaying substantial homology to the hydrolase
domain of RelA/SpoT bifunctional enzymes (Figure 7B).
Sequence analysis of ppGpp-synthesizing DspoT clones
We next analyzed the possibility that mutations in other gene(s)
could be co-selected with those described above in relA to help
compensating the deleterious effects of SpoT loss in the above
DspoT clones. In this context suppressor mutations in rpoB have
been found to relieve the toxic effects of high cellular levels of
ppGpp [9,47]. High ppGpp strains have been also found to
accumulate mutations in rpoS [48]. The rpoZ gene product has
been recently shown to be crucial for ppGpp-RNA polymerase
interactions, and could therefore provide a source of suppressor
mutations [49,50]. Mutations at the rplK (formerly relC) locus
coding for ribosomal protein L11 involved in RelA activation [9]
could have also been selected in cells overproducing ppGpp. In
turn, ppGpp-deficient strains have been found to accumulate
suppressor mutations in rpoB, rpoC, or rpoD [9]. Mutations in
genes coding for mediators or targets of ppGpp actions such as
dksA, rsd, or ssrS [9–12] could have also been selected to
compensate altered cellular ppGpp levels. However, Sanger
sequence analysis of rpoB, rpoS, rsd, ssrS, rpoC, rpoZ and dksA
in all the 19 DspoT clones studied here revealed in all cases
identical sequences to the corresponding genes in the WT strain
(Table 1). Moreover, high-throughput genome sequence analysis
of five selected DspoT clones (clones 5, 10, 11, 12 and 13, see
Table 2) not only confirmed the above Sanger sequence analyses,
but also failed to identify mutations at the rplK or rpoD loci that
could have been co-selected with the relA mutations present in
these clones. Furthermore, the whole genome sequencing of the
five selected DspoT clones revealed that the mutations are mainly
restricted to relA. As shown in Table 2, three of these clones
showed only mutations in relA in their genomes including a
premature stop codon in DspoT clone #5, and missense changes
in relA in DspoT clones #11 and #12. In turn, and besides
missense changes in relA, additional mutations were detected in
yejB and glnB (DspoT clones #10 and #13, respectively), which
have not been characterized as genetically linked to relA [9].
The observation that only few mutated loci other than relA are
present in the genomes of the E. coli DspoT clones analyzed here is
noteworthy, especially when compared to other bacteria such as
the Gram positive species Bacillus subtilis in which more changes
were identified in their genomes accompanying the mutations
compensating the lack of the RelA/SpoT bifunctional enzyme
present in these organisms [51]. The overall results shown above
Figure 5. Kinetics of cell growth, glycogen accumulation, and
expression of chromosomal glgB::lacZY fusions in representa-
tive ppGpp-less and ppGpp-containing DspoT clones cultured
in liquid KM. Time-course of (A) cell growth, (B) expression of
chromosomal glgB::lacZY fusions, and (C) glycogen accumulation of WT
cells and representative DspoT clones displaying either no detectable
ppGpp (clones 3 and 7) or significant ppGpp accumulation (clones 9
and 11).
doi:10.1371/journal.pone.0106938.g005
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thus reinforced the notion that the mutations in relA described in
this work represent bona fide suppressors of total spoT loss in E.
coli, and that relA mutations are predominantly selected to
compensate the detrimental effects of SpoT mutational loss in this
bacterial species [9].
Additional and concluding remarks
The aim of this work was to better understand the details of
ppGpp control on E. coli glycogen metabolism. The results of this
work reinforced the role of ppGpp as a main positive regulator of
glycogen gene expression and glycogen accumulation in E. coli
[2,5,7]. Moreover, they expanded our knowledge on the threshold
basal levels of ppGpp required to trigger net glycogen accumu-
lation in E. coli K-12, which were estimated here in around
4 nmoles ppGpp/g DW by the use of a highly sensitive MS/
HPLC procedure. These relatively low values are more compat-
ible with ppGpp cellular levels related to the induction of amino
acid biosynthetic operons as external sources are exhausted than to
the much higher values associated with severe growth impairments
and the induction of RpoS-mediated stress responses [17,18].
In the course of our studies we constructed and characterized a
series of spoT null mutants of E. coli K-12 which were obtained by
transducing a DspoT null allele from DrelADspoT cells into relA+
receptor bacteria followed by selection in LB rich medium.
Different sequencing approaches conducted here on distinct
DspoT clones confirmed that relA represents the primary source
of suppressor mutations compensating the deleterious effects of
SpoT loss in E. coli. Expectedly, different inactivating mutations
were found in relA such as those present in DspoT clones #1–8
which lacked detectable ppGpp production and thus both
glycogen gene expression and accumulation (Figures 3, 4, 5).
Remarkably however, around half of the DspoT mutants obtained
after transduction (clones #9–19) contained missense mutations at
the relA region encoding the N-terminal catalytic domain that
generated stable, full-length RelA variants retaining substantial
ppGpp synthesizing capability. These RelA variants showed
altered regulation as showed by the significant basal levels of
ppGpp found in these cells as compared to WT cells during
exponential growth in KM. Yet, and similar to WT RelA, these
mutant variants were also activated as cell growth proceeded into
the stationary phase as judged by both ppGpp determinations and
steady increases on both glycogen gene expression and accumu-
lation (Figures 3, 4, 5).
To our knowledge this is the first report describing the
systematic production of spoT null mutants of E. coli in which
relA suppressor alleles encoding enzymes retaining both significant
ppGpp synthesizing and regulatory capabilities have been selected.
Results presented in this work opened questions on how RelA
activity is controlled in DspoT clones 9–19 during growth in KM
within limits compatible with optimal growth. The absence of
ppGpp over-accumulation in these clones in the stationary phase
could be ascribed to altered kinetic properties of the mutant RelA
proteins, or alternatively to the occurrence of ppGpp degradative
enzymes that help preventing the building up of toxic ppGpp
levels. In this respect we must emphasize that, although it is
generally assumed that SpoT represents the main E. coli ppGpp
degradative enzyme [9–12], other poorly characterized activities
may also play role(s) in preventing ppGpp over-accumulation
[9,52–54].
Both RelA and SpoT form part of a sequence-related
superfamily of enzymes (RelA/SpoT or Rsh) of around 700–800
amino acid residues present in both bacteria and plants, which are
devoted to (p)ppGpp synthesis and breakdown [9–12]. Many
members of this superfamily, such as the enzymes present in many
Gram-positive bacteria and E. coli SpoT itself, are bifunctional
enzymes endowed with both (p)ppGpp synthetase and hydrolase
activity [9–12]. E. coli RelA and its close sequence homologs are
considered specialized monofunctional ppGpp synthetases gener-
ally lacking hydrolase activity [9–12,45,55,56]. Both bifunctional
and monofunctional enzymes are composed by an N-terminal
region bearing the catalytic site(s), and a C-terminal region
responsible of regulatory functions on the N-terminal domain
Figure 6. Growth behavior of DrelA single mutants, DrelADspoT double mutants, and four representative DspoT clones cultured in
M9-glucose medium. Growth in glucose-containing M9 minimal medium of DrelA and DrelADspoT mutants as well as of representative ppGpp-less
(3 and 7) and ppGpp-containing (9 and 11) DspoT clones. All DspoT cells tested were transformed with the empty plasmid vector pCA24N-EV or with
pCA24N-spoT expressing the cloned spoT gene (p-spoT) as indicated in the inset. Aliquots were taken at the indicated times for Abs600 measurements.
For details see Materials and Methods.
doi:10.1371/journal.pone.0106938.g006
relA Suppressors of Total spoT Loss in E. coli
PLOS ONE | www.plosone.org 12 September 2014 | Volume 9 | Issue 9 | e106938
Figure 7. Schematic representation and sequence characterization of the different relA mutations identified in the DspoT clones
studied here. A. The designation of each DspoT clone characterized in this work is indicated below the E. coli relA gene representation. The RelA
region encoding the N-terminal 455 amino acid residues bearing ppGpp synthetase activity [9,45] is shadowed. B. Amino acid sequence comparisons
of the N-terminal regions (,400 amino acid residues) of S. equisimilis Rsh, E. coli RelA, and SpoT. The alignments of the corresponding regions were
constructed by using ClustalW (http://www.genome.jp/tools/clustalw) using default parameters, and subsequently refined to maximize secondary
structure similarities between S. equisimilis Rsh [46] and RelA (as predicted by Jpred3; http://www.compbio.dundee.ac.uk). The corresponding amino
acid sequence positions are indicated at the right. Identical (*) or conserved (:) amino acids at a given position among the three sequences are
indicated below the alignments, and deletions/insertions by hyphens (2). The sequence regions spanning the ppGpp hydrolase (C E) and synthetase
(C| E| ) domains of S. equisimilis Rsh, as well as the central-3 helix bundle region joining these domains defined by the E and C| boundaries [46] are
indicated above the alignments. The different amino acid substitutions and the Trp39 deletion (D) identified in E. coli RelA in DspoT clones 8–19 (this
work) are indicated below the alignments. Conservation of equivalent residues in S. equisimilis Rsh and E. coli SpoT is indicated by highlighting the
corresponding amino acids in bold. Conserved residues whose site-directed mutagenesis has been found by other authors to promote loss (G251E)
or reductions (H354Y) in E. coli RelA ppGpp synthesis capability [45] are indicated by closed arrowheads below the alignments. The HDXXED motif
typical of metal-dependent pyrophosphohydrolases located in the hydrolase domain of bifunctional enzymes [46,55] is underlined. In turn, the
synthetase domain motif distinguishing monofunctional (EXDD) from bifunctional (RFKD) enzymes [46,55,56] is double underlined. The sources of the
sequences were: S. equisimilis Rsh, ref. 46; E. coli K-12 MG1655 SpoT, GenBank accession NP_418107.1; E. coli RelA BW25113: this work. The latter is
identical to E. coli K-12 MG1655 RelA, GenBank accession NP_417264.1.
doi:10.1371/journal.pone.0106938.g007
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derived from its interaction with the ribosome and other effectors,
oligomerization, etc. [9–12,45,46,54]. The synthetase and hydro-
lase domains of the N-terminal region of the Rsh bifunctional
enzyme from Streptococcus equisimilis were found to reside in
separate domains within the first 385 amino acid residues of this
protein [46] (Figure 7B). Evidence for cross-talk/reciprocal
regulation between these two antagonistic catalytic domains has
been derived from different structural and mutagenesis analyses
[10,46,54]. In addition, the amino acid sequence homology
existing between the N-terminal regions of RelA, SpoT and Rsh
proteins (Figure 7B) suggests that, besides some functional
differences among these enzymes, all share similar ppGpp
synthetase catalytic domains [9–12]. Previous site-directed muta-
genesis studies of conserved residues located in the proposed
synthetase domain of E. coli RelA that resulted in either loss
(G251E) or reductions (H354Y) of ppGpp synthesis capability also
supported this notion [45]. However, since these findings, a
number of differences have been found between bifunctional and
monofunctional enzymes, such as a charge reversal in a motif
located in the synthetase domain (Figure 7B) (which may account
for differential metal-mediated catalytic mechanisms), GTP/GDP
substrate specificity, cooperativity, regulation of the N-terminal
catalytic activities by the C-terminal region, and even a new
catalytic activity [55,56]. Also, the sequence homology detected
between bifunctional enzymes and RelA at the level of the
hydrolase domain (Figure 7B) raised other questions such as
whether the latter may have residual or cryptic ppGpp hydrolase
activity [9]. Although RelA lacks the conserved HDXXED motif
typical of metal-dependent phosphohydrolases [46,55,56], the
possibility still exists that such activity could be invoked by certain
amino acid substitutions. Other evolutionary pressures could
alternatively be involved in the preservation of a hydrolase-like
domain in monofunctional enzymes, which may be more related
to the regulation of the nearby ppGpp synthetase domain similar
to the case of bifunctional enzymes discussed above.
Many of the questions posed above can be addressed by the
relatively straightforward relA mutant generation procedure
described here. In fact, and as proof of concept, it served to
support an essential function of Ser258 for E. coli RelA ppGpp
synthetase activity (this work). In S. equisimilis Rsh the equivalent
Ser residue (Ser247) forms part of the a13 helix of the a13/b4
ppGpp synthetase catalytic loop, and mutational replacements of
this residue impaired ppGpp synthesis [46]. The overall observa-
tions thus suggest similarities between the catalytic mechanisms
operating in monofunctional and bifunctional enzymes.
The procedure reported here was useful to identify novel amino
acid residues in E. coli RelA whose mutational replacements
resulted in reductions of ppGpp synthesis capability such as
His219, Glu220, Tyr228, Pro253, Gly318, and Glu351, all located
in the synthetase domain of this enzyme (Figure 7). Notably,
however, all replacements found at these residues apparently
reduced but not abolished RelA ppGpp synthesis capability, an
observation that certainly deserves further studies. A similar
situation was found for Glu197, a conserved residue located in the
region spanning between the hydrolase-like and synthetase
domains of RelA (Figure 7). It is worth remarking that all
mutations found in the equivalent central-3 helix bundle region of
S. equisimilis Rsh impaired ppGpp hydrolase rather than
synthetase activity [46]. These observations suggest that differ-
ences also exist between monofunctional and bifunctional enzymes
which are originated in sequence regions distinct from the charge
reversal motif recently described [55,56]. Most remarkably, amino
acid mutations in the hydrolase homolog domain of RelA such as
the deletion of Trp39 and the replacements of residues Arg96,
Gln131, and Ile116 (which is located in a 6-residue stretch that is
missing in bifunctional enzymes) (Figure 7B) were all found to
reduce ppGpp synthesis capability. This suggests that reciprocal
regulation between these two separate N-terminal domains also
exists in E. coli RelA, a situation that would provide a reasonable
explanation for the overall sequence conservation found all along
Figure 8. Western blot analysis of RelA in WT, and in the 19 selected DspoT clones. The gel was loaded with 70 mg per lane of total soluble
proteins of each of the described cells. The different bacterial strains were cultured in liquid KM and harvested after 7 h of culture. This figure is a
composite of 3 different western blot scans, whose separation is indicated by dotted lines.
doi:10.1371/journal.pone.0106938.g008
Table 2. Description of mutations identified by whole genome sequencing of five DspoT clones (5, 10, 11, 12 and 13).
Gene DspoT clone Ecogene description Mutation Effect
relA 5, 10, 11, 12, 13 ppGpp synthase I; ppGpp
synthesis during stringent response
See Table 1 See Table 1
glnB 13 PII regulatory protein
for glutamine synthase




yejB 10 Microcin C transporter YejABEF, permease
subunit; ABC family
G for T change at nt
position 142
Production of a truncated polypeptide of
47 amino acids
doi:10.1371/journal.pone.0106938.t002
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this region between monofunctional and bifunctional enzymes
(Figure 7B). In addition, it helped identifying some amino acid
residues potentially involved in regulatory actions interconnecting
both RelA domains.
The procedure described here thus provides a useful tool for a
better understanding of the structure/function relationships of
RelA monofunctional members of the Rsh family. Yet, ppGpp
plays important roles in aspects beyond glycogen metabolism
including the activation of the Lrp regulon and thus amino acid
biosynthetic operons, catabolite de-repression, DNA synthesis,
rRNA and tRNA synthesis, fatty acid metabolism, stress responses,
surface organelle and biofilm production, pathogenesis, etc. [9–
12,17,18]. Therefore, the series of mutants obtained in this work,
and the simple glycogen iodine-staining based method useful for
the identification of relA suppressor mutations in a variety of
bacterial backgrounds, may help future studies of ppGpp-
mediated regulation of the above biological processes under
different scenarios.
Supporting Information
Figure S1 Production of DspoT BW25113 cells. The
presence of the DspoT::Spc deletion allele in the 19 selected
Spc-resistant clones was confirmed by PCR using the O1 and O2
primers flanking the site of the mutation (upper panel) and by the
inability to amplify spoT by PCR using the spoT specific internal
primers O3 and O4 (lower panel) (Table S2). The same results
were obtained using other K-12 and B DspoT::Spc strains
constructed in this work (not shown). The figure represents a
composite of two different gels, whose separation is indicated by
dotted lines.
(TIF)
Figure S2 Scheme illustrating the location of the
different primers described in Table S2 used for PCR
amplification of the different E. coli loci analyzed in this
study. The different loci analyzed and the expected hybridization
regions of the corresponding sets of forward and reverse primers
are indicated above each of the figures. The length of each of the
corresponding genes and their neighboring regions (in bp) are also
indicated.
(TIF)
Table S1 Oligonucleotides used for PCR constructions
employed in the deletion of the E. coli spoT gene. spoT
deletion was done following the method of Datsenko and Wanner
[24]. Priming sequences for the Spc resistance gene are indicated
in bold.
(DOC)
Table S2 Oligonucleotide primers used for PCR ampli-
fication of the different E. coli loci analyzed in this
study. For further details see Figure S2.
(DOC)
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